文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Artificial intelligence for prostate cancer diagnostics.

作者信息

Rannikko Antti S

机构信息

Department of Urology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

出版信息

Nat Cancer. 2025 Sep 2. doi: 10.1038/s43018-025-01034-w.


DOI:10.1038/s43018-025-01034-w
PMID:40897910
Abstract
摘要

相似文献

[1]
Artificial intelligence for prostate cancer diagnostics.

Nat Cancer. 2025-9-2

[2]
Men's sociotechnical imaginaries of artificial intelligence for prostate cancer diagnostics - A focus group study.

Soc Sci Med. 2024-4

[3]
Development and retrospective validation of an artificial intelligence system for diagnostic assessment of prostate biopsies: study protocol.

BMJ Open. 2025-7-7

[4]
Stimulated Raman Histology Interpretation by Artificial Intelligence Provides Near-Real-Time Pathologic Feedback for Unprocessed Prostate Biopsies.

J Urol. 2024-3

[5]
An Artificial Intelligence Model Using Diffusion Basis Spectrum Imaging Metrics Accurately Predicts Clinically Significant Prostate Cancer.

J Urol. 2025-6

[6]
Artificial intelligence-powered advancements in atrial fibrillation diagnostics: a systematic review.

Egypt Heart J. 2025-7-23

[7]
Utilization of Artificial Intelligence Algorithms for the Diagnosis of Breast, Lung, and Prostate Cancer.

Cesk Patol. 2025

[8]
Digital Pathology-based Artificial Intelligence Biomarker Validation in Metastatic Prostate Cancer.

Eur Urol Oncol. 2025-6

[9]
The promising role of new molecular biomarkers in prostate cancer: from coding and non-coding genes to artificial intelligence approaches.

Prostate Cancer Prostatic Dis. 2022-9

[10]
External Validation of an Artificial Intelligence Algorithm Using Biparametric MRI and Its Simulated Integration with Conventional PI-RADS for Prostate Cancer Detection.

Acad Radiol. 2025-7

本文引用的文献

[1]
Screening for prostate cancer: evidence, ongoing trials, policies and knowledge gaps.

BMJ Oncol. 2023-4-20

[2]
Artificial intelligence and radiologists in prostate cancer detection on MRI (PI-CAI): an international, paired, non-inferiority, confirmatory study.

Lancet Oncol. 2024-7

[3]
The Lancet Commission on prostate cancer: planning for the surge in cases.

Lancet. 2024-4-27

[4]
Prostate Cancer Screening With PSA, Kallikrein Panel, and MRI: The ProScreen Randomized Trial.

JAMA. 2024-5-7

[5]
Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only.

N Engl J Med. 2022-12-8

[6]
Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management.

J Urol. 2022-7

[7]
MRI-Targeted or Standard Biopsy in Prostate Cancer Screening.

N Engl J Med. 2021-9-2

[8]
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis.

N Engl J Med. 2018-3-18

[9]
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study.

Lancet. 2017-1-20

[10]
Screening and prostate-cancer mortality in a randomized European study.

N Engl J Med. 2009-3-26

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索